CASSINI Trial publishes data on preventing blood clots in cancer patients
(Fred Hutchinson Cancer Research Center) The first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood clots in patients with cancer at high-risk published today in the New England Journal of Medicine. The study found no significant reduction in venous thromboembolism or death in the overall 180-day trial period; however, the researchers did observe a lower incidence of these events while patients were actively on the study drug, or during the on-treatment period. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 20, 2019 Category: Cancer & Oncology Source Type: news

Gastric Acid Suppression & Oral Cancer Therapy Should Not Mix Gastric Acid Suppression & Oral Cancer Therapy Should Not Mix
Gastric acid suppressants may reduce absorption of oral cancer drugs, as shown in a study with pazopanib for sarcoma in which the interaction led to worse outcomes. Can this be practice changing?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 19, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Grandmother was diagnosed with tongue cancer after an 'ulcer' swelled to the size of a MALTESER
Joanna Smith, 58, of Clapham, Bedfordshire, first realised something was wrong when she spotted a tiny 'ulcer' in her mouth in October last year, which then grew and became painful. (Source: the Mail online | Health)
Source: the Mail online | Health - February 18, 2019 Category: Consumer Health News Source Type: news

14.02.19: Not intended for U.S. and UK Media - American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) 2019
Bayer's darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival with a favorable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancerStatistically significant improvement in metastasis-free survival (MFS), with a median MFS of 40.4 months with darolutamide plus androgen deprivation therapy (ADT) versus placebo plus ADT (18.4 months) / Positive trend in overall survival with a 29% reduction in risk of death at interim analysis (P=0.045) / Incidence of treatment-emergent adverse events was similar for darolutamide plus ADT and placebo p...
Source: Bayer IR Newsfeed: Events - February 15, 2019 Category: Pharmaceuticals Source Type: news

Bayer & #8217;s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival with a favorable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer (for specialized target groups only)
Statistically significant improvement in metastasis-free survival (MFS), with a median MFS of 40.4 months with darolutamide plus androgen deprivation therapy (ADT) versus placebo plus ADT (18.4 months) / Positive trend in overall survival with a 29% reduction in risk of death at interim analysis (P=0.045) / Incidence of treatment-emergent adverse events was similar for darolutamide plus ADT and placebo plus ADT / Health-related quality of life was maintained / First results from the Phase III ARAMIS trial with the androgen receptor antagonist darolutamide were presented in an oral presentation at American Society of Clinic...
Source: Bayer Company News - February 14, 2019 Category: Pharmaceuticals Source Type: news

Sexually transmitted infections are on the rise. Here ’s what you need to know to protect yourself
UCLA Health Rates of sexually transmitted diseases have risen for the past four years to record highs in the United States, according to the Centers for Disease Control and Prevention ’slatest analysis. In California, the state health departmentfound that the number of people diagnosed with syphilis, gonorrhea or chlamydia in 2017 was 45 percent higher than five years prior.These sorts of statistics may spark a fear that there ’s little we can do to protect ourselves — but that’s not the full story.Dr. Leena Nathan, an obstetrician/gynecologist at UCLA Health-Westlake Village, consults with peo...
Source: UCLA Newsroom: Health Sciences - February 14, 2019 Category: Universities & Medical Training Source Type: news

E-cig users develop some of the same cancer-related molecular changes as cigarette smokers
(University of Southern California) A USC study in 93 people shows that e-cig users develop some of the same cancer-related molecular changes in oral tissue as cigarette smokers, adding to the growing concern that e-cigs aren't a harmless alternative to smoking. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 14, 2019 Category: International Medicine & Public Health Source Type: news

Why lemons are a cheap but effective way to maintain good oral hygiene
(Natural News) Maintaining good oral hygiene does not need expensive mouthwash or toothpaste. Instead, use lemons. Lemons and other citrus fruits have been associated with many health benefits, such as a lowered risk for gastrointestinal and esophageal cancer, and cardiovascular diseases. In a recent study, it was also revealed that the extract of the rind... (Source: NaturalNews.com)
Source: NaturalNews.com - February 12, 2019 Category: Consumer Health News Source Type: news

Cross-species cancer comparison uncovers new drug targets, study reveals
(University of Guelph) Mucosal melanoma arises in non-skin locations such as sinuses, nasal passages and mouth. The research team sequenced the genomes of mucosal melanoma tumours from 46 humans, 65 dogs and 28 horses and discovered a handful of genes that were commonly mutated in all species.These genetic similarities point to the drivers of the disease -- key information that will lead to using biologically relevant drug targets. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2019 Category: Cancer & Oncology Source Type: news

Scientists to test light therapy as relief from painful side effect of cancer treatment
(University at Buffalo) University at Buffalo researchers have received part of a $1.5 million grant to investigate light therapy as a replacement for prescription opioids in treating oral mucositis, painful ulcers and swelling in the mouth that result from chemotherapy and radiation treatment for cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 11, 2019 Category: Cancer & Oncology Source Type: news

New study shows HPV not likely transmittable through the hand
(McGill University) Commonly known as HPV, Human papillomavirus is a virus that infects the skin and genital area, in many cases leading to a variety of genital, anal, and oropharyngeal cancers in men and women. Strong evidence exists showing that penetrative genital sex and oral sex can transmit HPV. However, while HPV is also often detected in the hands, the question of whether hand-genital contacts can transmit HPV has long been a source of debate among researchers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 11, 2019 Category: International Medicine & Public Health Source Type: news

Digital Pill May Improve Adherence to Oral Cancer Drugs Digital Pill May Improve Adherence to Oral Cancer Drugs
Oral drugs combined with a sensor can alert clinicians and caregivers when medication has been taken; a pilot trial with a digital capecitabine is underway in colorectal cancer patients.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 6, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Certain symptom combos not in current guidance are red flags for throat cancer
Sore throat plus swallowing or breathing difficulties or ear pain predictive of laryngeal cancer, study shows Related items fromOnMedica Tell patients to use paracetamol for sore throat, urge NICE and PHE Call for closer links between GPs and dentists Air pollution link to heightened mouth cancer risk Public awareness of mouth cancer symptoms low, despite sharp rise in cases GPs need better test access to improve cancer diagnosis (Source: OnMedica Latest News)
Source: OnMedica Latest News - February 5, 2019 Category: UK Health Source Type: news

It's time for Ruth Bader Ginsburg to either show her face or RESIGN from the Supreme Court
(Natural News) Supreme Court Justice Ruth Bader Ginsburg has not been seen in public since she underwent surgery to remove several cancerous lung growths back in December. The 85-year-old has cancelled all public appearances since then and has not attended any oral arguments before the Supreme Court, and rumors are swirling that she is either... (Source: NaturalNews.com)
Source: NaturalNews.com - February 4, 2019 Category: Consumer Health News Source Type: news

Uganda: Let's Join Fight Against Cancer
[Monitor] World Cancer Day is celebrated every February 4. It is a day when organisations and people around the world unite to raise awareness about cancer and work to make it a global health priority. Cancer is the uncontrolled growth of abnormal cells in the body. These cells can begin to grow from any part of the body such as liver, kidney, pancrease, lungs, cervix, prostate gland, eyes, mouth, and breast, among others. An estimated 9.5 million people worldwide were expected to die from cancer in 2018 - about 26, (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 4, 2019 Category: African Health Source Type: news

Recognising laryngeal cancer in primary care: a large casecontrol study using electronic records
This study (n=806) found 10 features significantly associated with laryngeal cancer: hoarseness, sore throat-first attendance; sore throat-re-attendance, dysphagia, otalgia, dyspnoea-re-attendance, mouth symptoms, recurrent chest infection, insomnia and raised inflammatory markers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 30, 2019 Category: Consumer Health News Source Type: news

Association between breast cancer chemotherapy, oral health and chronic dental infections: a pilot study
Odontology pp 1 –8 |Cite asOriginal ArticleFirst Online:21 January 2019AbstractBreast cancer has developed to become the leading type of cancer in females. For this study, 80 women were examined after chemotherapy for breast cancer and compared to 80 healthy age-matched women. This cross-sectional study comprised a dental examination with number of teeth, caries frequency (DMFT) and the presence of periodontal diseases (PSI). With the help of X-rays (OPG), the number of root canal fillings and apical lesions (LEO/LPO) were recorded. Furthermore, the education level, body mass index (BMI), smoking habits and general h...
Source: Dental Technology Blog - January 30, 2019 Category: Dentistry Source Type: news

Tongue microbiome could help identify patients with early-stage pancreatic cancer
(Taylor& Francis Group) Differences in the abundance of certain bacteria living on the tongue can distinguish patients with early pancreatic cancers from healthy individuals, according to results from a new study published in the Journal of Oral Microbiology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 28, 2019 Category: Cancer & Oncology Source Type: news

Cancer symptoms: Why you should ALWAYS see a GP if you have long-lasting mouth ulcers
CANCER symptoms are not always obvious and some can be confused with everyday problems and much less serious conditions. One such symptom which can easily be overlooked are mouth ulcers and tongue ulcers. (Source: Daily Express - Health)
Source: Daily Express - Health - January 23, 2019 Category: Consumer Health News Source Type: news

Proteus debuts digital cancer drug
Proteus Digital Health said today that the first cancer patients were treated using its digital oncology therapy, which combines oral chemotherapy with an ingestible sensor. Patients with stage 3 and 4 colorectal cancer at the University of Minnesota Health and Fairview Health Services were treated with digital capecitabine. The Redwood City, Calif.-based company plans to use its sensor-drug combination to record and share data such as the time and dose of chemotherapy that a patient ingests. Get the full story at our sister site, Drug Delivery Business News. The post Proteus debuts digital cancer drug appeared first ...
Source: Mass Device - January 17, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Featured mHealth (Mobile Health) Oncology Pharmaceuticals Proteus Digital Health Source Type: news

Amateur motorcyclist discovered he had mouth cancer after his wisdom tooth was removed
Andy Gale, 50, of  Bridgwater, Somerset was told he had stage-four squamous cell carcinoma in January 2014 after the wound left behind by a removed wisdom tooth failed to heal. (Source: the Mail online | Health)
Source: the Mail online | Health - January 17, 2019 Category: Consumer Health News Source Type: news

Advanced squamous cell carcinoma of the head and neck: Pembrolizumab prolongs survival
(Institute for Quality and Efficiency in Health Care) quamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumours of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable. The goal is then to prolong the remaining lifetime while maintaining the best possible quality of life. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2019 Category: International Medicine & Public Health Source Type: news

Certain Dental Flosses Raise Body Levels of Toxic Chemicals Certain Dental Flosses Raise Body Levels of Toxic Chemicals
Flossing teeth with Oral-B Glide and similar brands could inadvertently increase exposure to PFAS chemicals, a number of which have been linked to cancer and thyroid disease, a US study indicates.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 16, 2019 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Flossing with Oral B Glide 'causes a build-up of toxic chemicals in your body that cause cancer'
A study by the Silent Spring Institute found using the go-to brand as part of your oral-health regimen is associated with a higher level of PFAS chemicals in the bloodstream. (Source: the Mail online | Health)
Source: the Mail online | Health - January 9, 2019 Category: Consumer Health News Source Type: news

Allow Docs to Recycle Chemo Pills, Already Allow Docs to Recycle Chemo Pills, Already
Currently, some physicians take discarded oral cancer drugs from one patient and pass them on to another, but the activity occurs in a legally murky zone.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 9, 2019 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news

Dental flossing and other behaviors linked with higher levels of PFAS in the body
(Silent Spring Institute) A new study suggests certain types of consumer behaviors, including flossing with Oral-B Glide dental floss, contribute to elevated levels in the body of toxic PFAS chemicals. The findings provide new insight into how these chemicals end up in people's bodies and how consumers can limit their exposures by modifying their behavior. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 8, 2019 Category: Cancer & Oncology Source Type: news

Husband slams a hospital for delaying his cancer-stricken wife's life-saving surgery THREE TIMES
Derek Lewthwaite, 65, of Blackpool, claims his wife Jane Lewthwaite, 64 - who was diagnosed with mouth cancer two months ago - is in a race against time while she waits for a critical operation. (Source: the Mail online | Health)
Source: the Mail online | Health - January 3, 2019 Category: Consumer Health News Source Type: news

Tragara Pharmaceuticals Appoints Scott Megaffin as Chief Executive Officer and Changes Name to Adastra Pharmaceuticals
Company Well-Positioned for Next Phase of Clinical Advancement with Lead Oral Drug Candidate, TG02, for Treatment of Adult and Pediatric Brain Cancers PRINCETON, N.J. and SAN DIEGO, Jan. 3, 2019 -- (Healthcare Sales & Marketing Network) -- Tragara Phar... Biopharmaceuticals, Oncology, Personnel Adastra Pharmaceuticals, Tragara Pharmaceuticals, glioblastoma multiforme (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 3, 2019 Category: Pharmaceuticals Source Type: news

Health Tip: How Alcohol May Raise Cancer Risk
-- Alcohol use has been associated with cancers of the mouth, throat, voice box, esophagus, liver, colon, rectum and breast, the American Cancer Society says. The society describes how alcohol can affect the body, noting that the more you drink,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 19, 2018 Category: General Medicine Source Type: news

Vitamin E TPGS emulsified vinorelbine bitartrate loaded solid lipid nanoparticles (SLN)
(Bentham Science Publishers) Vinorelbine bitartrate (VRL), a semi synthetic vinca alkaloid approved for breast cancer, has been proven to be beneficial as first line and subsequent therapies. However, its hydrophilic and thermo labile nature provides hindrance to oral clinical translation. The current work focused on the application of DOE a modern statistical optimization tool for the development and optimization of a solid lipid nanoparticle (SLN) formulation that can encapsulate hydrophilic and thermolabile Vinorelbine bitartrate (VRL) to a maximum extent without compromising integrity and anticancer activity of the dru...
Source: EurekAlert! - Cancer - December 14, 2018 Category: Cancer & Oncology Source Type: news

Ultrarestrictive opioid prescribing strategy associated with fewer pills dispensed
(JAMA Network) An ultrarestrictive opioid prescribing strategy was associated with a reduction in the number of pills dispensed in a study of patients having surgery   for gynecologic cancer, without changes in postoperative pain scores, complications or increases in prescription refill requests. Under the protocol,   patients having ambulatory or minimally invasive surgery weren't prescribed opioids at discharge unless they required more than five doses of oral or intravenous opioids while in the hospital. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 7, 2018 Category: International Medicine & Public Health Source Type: news

Lymph node ratio may predict who lives and dies from oral cavity cancer
(University of Colorado Anschutz Medical Campus) Patients with lymph node ratio greater than 10 percent had about 2.5 times greater risk of cancer recurrence and 2.7 times greater risk of death than patients with LNR below 10 percent. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Radiation therapy's pivotal role in treating breast cancer featured at SABCS 2018
(American Society for Radiation Oncology) This year's San Antonio Breast Cancer Symposium (SABCS) features a record number of radiation oncology trials among its oral presentations. Today's General Session 4 (3:15-5:00 p.m. CT in Hall 3) will showcase five major studies designed to improve outcomes for the majority of breast cancer patients who receive radiation therapy to cure and/or provide relief from the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Do Oral Side Effects Affect Fentanyl Delivery in Head & amp; Neck Cancer Patients?
Erin McMenamin, CRNP, of Penn Medicine, discusses how oral side effects affect head and neck cancer patients. (Source: CancerNetwork)
Source: CancerNetwork - December 4, 2018 Category: Cancer & Oncology Authors: Lori Smith, BSN, MSN, CRNP Source Type: news

Medical News Today: Does HIV increase cancer risk?
HIV can weaken a person ’s immune system, which can increase the risk of certain types of cancer. Such cancers include Kaposi’s sarcoma, non-Hodgkin lymphoma, and cervical, lung, anal, and oral cancer. However, effective treatment can significantly reduce the risk of developing these cancers. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 4, 2018 Category: Consumer Health News Tags: HIV and AIDS Source Type: news

' Marginal Benefit' With Rivaroxaban in Cancer Patients'Marginal Benefit' With Rivaroxaban in Cancer Patients
The oral drug rivaroxaban was used for prophylaxis against primary venous thromboembolism in ambulatory cancer patients treated in the outpatient setting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 4, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Oral cancer prognostic signature identified
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) Discovery based on analysis of tissue and saliva samples from oral cancer patients shows a correlation between a signature comprising three peptides and the presence of lymph node metastasis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

Drug dramatically reduces risk of dangerous blood clots in cancer patients
(The Ottawa Hospital) A large clinical trial published in the New England Journal of Medicine provides the first approach for safely preventing blood clots (venous thromboembolism) in people with cancer. Venous thromboembolism is the second leading cause of death in cancer patients and it can also affect quality of life. About half of people newly diagnosed with a solid cancer could be candidates for the strategy, which involves a low dose of a direct oral anticoagulant called apixaban. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

Cleveland Clinic-led study: Rivaroxaban reduced blood clots and related death in cancer patients
(Cleveland Clinic) Cleveland Clinic medical oncologist and researcher, Alok Khorana, M.D., is the primary investigator on a study that concluded rivaroxaban for venous thromboembolism (VTE), a blood clot in the venous system, significantly reduced VTE and VTE-related death for outpatient, at-risk cancer patients while they were taking the oral blood thinner. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 4, 2018 Category: Cancer & Oncology Source Type: news

Statins are being overprescribed, study suggests
The risks of statins for primary prevention are greater than the benefits for many patients Related items fromOnMedica Withdrawn valsartan meds not linked to short-term cancer risk Direct oral anticoagulants as safe as warfarin after VTE Too few women take part in many CVD clinical trials Use of DPP-4 inhibitors associated with increased risk of IBD Metformin doesn ’t help HbA1c in teens with type 1 diabetes (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 4, 2018 Category: UK Health Source Type: news

Oral drug for blood clot treatment safe for cancer patients, study says
A popular oral medication used to treat blood clots is safe and effective for patients going through cancer therapy, a study says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 3, 2018 Category: Consumer Health News Source Type: news

Trying to quit smoking? Acupuncture can help
(Natural News) Smoking does nothing good to the body. In fact, it’s a leading cause of disease and disability for almost every organ in the body. It increases the risk of multiple cancers, such as that of the lungs, mouth, throat, stomach, liver, and kidneys. At least 90 percent of lung cancer cases, in particular,... (Source: NaturalNews.com)
Source: NaturalNews.com - December 3, 2018 Category: Consumer Health News Source Type: news

Mayo researchers say oral apixaban safe and effective for treating blood clots in cancer patients
(Mayo Clinic) Mayo Clinic researchers have found that an oral drug, apixaban, used to treat blood clots in patients undergoing cancer therapy, is safe and effective. The drug was associated with fewer major bleeding events and fewer recurrent blood clots, compared to low-molecular- weight heparin. Their findings were presented at the annual meeting of the American Society of Hematology by Robert McBane II M.D., a Mayo Clinic cardiologist. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 3, 2018 Category: International Medicine & Public Health Source Type: news

Mayo researchers say oral apixaban safe and effective for treating blood clots in cancer patients
SAN DIEGO ??Mayo Clinic researchers have found that an oral drug, apixaban, used to treat blood clots in patients undergoing cancer therapy, is safe and effective. The drug was associated with fewer major bleeding events and fewer recurrent blood clots, compared to low-molecular- weight heparin. Their findings were presented at the annual meeting of the [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - December 3, 2018 Category: Hospital Management Source Type: news

How Useful Are Immune Checkpoint Markers in Squamous Cell Carcinoma?
A recent study examined the literature on whether immune checkpoint molecules improve overall survival in oral squamous cell carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - November 29, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Experts: Magic Mouthwash Should'Vanish Into Thin Air'Experts: Magic Mouthwash Should'Vanish Into Thin Air '
Mixed-medication mouth rinses are commonly used for oral pain and inflammation that accompany some cancer treatments. Should they be?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 28, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Injury threshold of oral contact with hot foods and method for its sensory evaluation - Lachenmeier DW, Lachenmeier W.
Epidemiological studies indicate an increased risk of esophageal cancer from the consumption of very hot foods and beverages. The contact time and the contact temperature are decisive for the risk of injury. However, measuring the contact temperature is no... (Source: SafetyLit)
Source: SafetyLit - November 28, 2018 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Increased Risk for Oral Cancer With Exposure to High PM2.5
Taiwanese men exposed to PM2.5 ≥ 40.37 µ g/m ³ have increased risk for oral cancer (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - November 20, 2018 Category: Respiratory Medicine Tags: Oncology, ENT, Pathology, Pulmonology, Journal, Source Type: news

Increased Risk for Oral Cancer With Exposure to High PM2.5
TUESDAY, Nov. 20, 2018 -- Taiwanese men exposed to high concentrations of fine particulate matter 2.5 (PM2.5) have an increased risk for oral cancer, according to a study recently published in the Journal of Investigative Medicine. Yu-Hua Chu, from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2018 Category: Pharmaceuticals Source Type: news

Mouth cancer symptoms: If your breath smells like this you could have the deadly disease
MOUTH cancer symptoms usually occur around the mouth, teeth and glands. An ulcer is one of the most notable signs, but if your breath smells a certain way this could also indicate the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - November 20, 2018 Category: Consumer Health News Source Type: news